Skip to main content
. 2015 Nov 24;11:591–594. doi: 10.2147/VHRM.S89842

Table 1.

Baseline and follow-up cardiac biomarkers of all patients

Baseline At follow-up Change

Median (25th, 75th percentiles)
cTnI (ng/mL) 0.00 (0.00, 0.01) 0.05 (0.01, 0.09) 0.04 (0.00, 0.08)
cTnT (ng/mL) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00)
CKMB (ng/mL) 0.80 (0.50, 0.80) 1.00 (0.70, 1.50) 0.40 (0.00, 0.90)
NT-proBNP(pg/mL) 46.10 (34.10, 106.10) 88.30 (67.80, 135.90) 20.50 (−11.50, 88.00)
hscTnT (pg/mL) 1.39 (0.00, 3.36) 19.10 (5.90, 28.70) 16.90 (4.10, 25.60)
Pre-MUGA EF (%) 58.00 (56.00, 58.00) 58.00 (53.00, 65.00) −3.00 (−6.00, 4.00)

Abbreviations: cTnI, cardiac troponin I; cTnT, cardiac troponin T; CKMB, creatine kinase MB; NT-proBNP, N-terminal pro-B-type natriuretic peptide; hscTnT, high-sensitivity cTnT; MUGA, multigated acquisition (equilibrium radionuclide ventriculography); EF, ejection fraction.